Randomized Clinical Trial
Copyright ©The Author(s) 2024.
World J Clin Cases. Jun 26, 2024; 12(18): 3491-3496
Published online Jun 26, 2024. doi: 10.12998/wjcc.v12.i18.3491
Table 3 Comparison results of serum motilin, 5-hydroxytryptamine, and vasoactive intestinal peptide levels between groups (mean ± SD)
Groups
Time
Serum motilin (ng/L)
5-hydroxytryptamine (pg/mL)
Vasoactive intestinal peptide (pg/mL)
Research group (n = 64)Before treatment253.24 ± 25.5463.54 ± 2.1875.54 ± 5.54
After treatment312.24 ± 28.6882.54 ± 6.4548.04 ± 2.15
Control group (n = 64)Before treatment252.87 ± 25.6863.64 ± 2.1775.61 ± 5.49
After treatment284.64 ± 26.0570.55 ± 6.5458.64 ± 3.24
t/P value Research group (before and after treatment)12.291/0.00022.325/0.00037.021/0.000
t/P value Control group (before and after treatment)6.948/0.0008.023/0.00021.296/0.000
t/P value Between-group values (before treatment)0.082/0.9350.260/0.7950.072/0.943
t/P value Between-group values (post-treatment)5.699/0.00010.443/0.00021.808/0.000